Health & Fitness
Mon, June 11, 2012
GAINESVILLE, Fla.--([ BUSINESS WIRE ])--Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials today announced that Dr. Bill Petty, Chairman and CEO, will present to analysts and investors at the Wells Fargo 2012 Healthcare Conference in Boston on Wednesday, June 20 at 2:10 p.m. Eastern time.
A live audio webcast and the slides of Exactechas investor presentation will be available at [ http://www.hawkassociates.com/profile/exac.cfm ] and will be archived for approximately 90 days.
About Exactech
Based in Gainesville, Fla., Exactech develops and markets orthopaedic implant devices, related surgical instruments and biologic materials and services to hospitals and physicians. The company manufactures many of its orthopaedic devices at its Gainesville facility. Exactechas orthopaedic products are used in the restoration of bones and joints that have deteriorated as a result of injury or diseases such as arthritis. Exactech markets its products in the United States, in addition to more than 30 markets in Europe, Latin America, Asia and the Pacific. Additional information about Exactech, Inc. can be found at [ http://www.exac.com ]. Copies of Exactechas press releases, SEC filings, current price quotes and other valuable information for investors may be found at [ http://www.exac.com ] and [ http://www.hawkassociates.com ].
An investment profile on Exactech may be found at [ http://www.hawkassociates.com/profile/exac.cfm ]. To receive future releases in e-mail alerts, sign up at [ http://www.hawkassociates.com/about/alert ].
This release contains various forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, which represent the companyas expectations or beliefs concerning future events of the companyas financial performance. These forward-looking statements are further qualified by important factors that could cause actual results to differ materially from those in the forward-looking statements. These factors include the effect of competitive pricing, the companyas dependence on the ability of third party manufacturers to produce components on a basis which is cost-effective to the company, market acceptance of the companyas products and the effects of government regulation. Results actually achieved may differ materially from expected results included in these statements.